Deborah Assayag

2.9k total citations
54 papers, 1.2k citations indexed

About

Deborah Assayag is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Deborah Assayag has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 23 papers in Physiology and 10 papers in Epidemiology. Recurrent topics in Deborah Assayag's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (48 papers), Sarcoidosis and Beryllium Toxicity Research (22 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers). Deborah Assayag is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (48 papers), Sarcoidosis and Beryllium Toxicity Research (22 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers). Deborah Assayag collaborates with scholars based in Canada, United States and Australia. Deborah Assayag's co-authors include Christopher J. Ryerson, Harold R. Collard, Joyce Lee, Talmadge E. King, Kerri A. Johannson, Pearce Wilcox, Jonathon Leipsic, Brett M. Elicker, Cameron Hague and Tiffany A. Winstone and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Radiology.

In The Last Decade

Deborah Assayag

47 papers receiving 1.2k citations

Peers

Countries citing papers authored by Deborah Assayag

Since Specialization

Citations

This map shows the geographic impact of Deborah Assayag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Assayag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Assayag more than expected).

Fields of papers citing papers by Deborah Assayag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Assayag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Assayag. The network helps show where Deborah Assayag may publish in the future.

Co-authorship network of co-authors of Deborah Assayag

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Assayag. A scholar is included among the top collaborators of Deborah Assayag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Assayag. Deborah Assayag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Racial, Ethnic, Sex, and Gender Equity for Inclusive Interstitial Lung Disease Research: An Official American Thoracic Society Research Statement 2025 ·American Journal of Respiratory and Critical Care Medicine ·Deborah Assayag, Ayodeji Adegunsoye, Yet H. Khor, Francesco Bonella, Raphaël Borie, Ivette Buendía-Roldán, Nazia Chaudhuri, Kevin F. Gibson, Kerri A. Johannson, Naftali Kaminski, John S. Kim, Sydney B. Montesi, Nadia Nathan, Anne‐Marie Russell, Claudia Valenzuela, Marlies Wijsenbeek, Vincent Cottin, Yolanda Mageto	0
2	Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis 2025 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Deborah Assayag, (unknown), Xiaoping Chen, Jolene H. Fisher, Kevin F. Gibson, Kerri A. Johannson, Daniel J. Kass, Nasreen Khalil, Martin Kolb, H. Manganas, Veronica Marcoux, Christopher J. Ryerson, (unknown), Yingze Zhang, Mehdi Nouraie, G.C. Goobie	1
3	Characteristics of pulse oximetry and arterial blood gas in patients with fibrotic interstitial lung disease 2024 ·BMJ Open Respiratory Research ·M Donaldson, (unknown), Deborah Assayag, (unknown), Jolene H. Fisher, Kerri A. Johannson, Martin Kolb, (unknown), H. Manganas, Veronica Marcoux, (unknown), Julie Morisset, (unknown), Christopher J. Ryerson	0
4	Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease 2024 ·American Journal of Respiratory and Critical Care Medicine ·Yet H. Khor, Kerri A. Johannson, Veronica Marcoux, Jolene H. Fisher, Deborah Assayag, H. Manganas, Nasreen Khalil, Martin Kolb, Christopher J. Ryerson	10
5	Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy: A Prospective Multi-Centre Agreement Clinical Trial (CAN-ICE) 2023 ·American Journal of Respiratory and Critical Care Medicine ·Marc Fortin, Moïshe Liberman, Antoine Delage, Geneviève Dion, Simon Martel, (unknown), Thibaud Soumagne, Sylvain Trahan, Deborah Assayag, (unknown), Margaret M. Kelly, Kerri A. Johannson, (unknown), Charles Leduc, H. Manganas, (unknown), Steeve Provencher	16
6	Impact of Antigen Exposure on Outcomes and Treatment Response in Fibrotic Hypersensitivity Pneumonitis 2023 ·CHEST Journal ·(unknown), (unknown), (unknown), Boyang Zheng, Alyson W. Wong, Deborah Assayag, Jolene H. Fisher, Kerri A. Johannson, Nasreen Khalil, Martin Kolb, H. Manganas, Veronica Marcoux, Julie Morisset, (unknown), Erica Farrand, Christopher J. Ryerson	3
7	Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort 2023 ·Journal of Thoracic Disease ·Veronica Marcoux, (unknown), Prosanta Mondal, Deborah Assayag, Jolene H. Fisher, Shane Shapera, Julie Morisset, H. Manganas, Charlene D. Fell, Nathan Hambly, Gerard Cox, Martin Kolb, Andrea S. Gershon, Teresa To, Mohsen Sadatsafavi, Nasreen Khalil, Alyson W. Wong, (unknown), Christopher J. Ryerson, Kerri A. Johannson	6
8	Clinical relevance of rheumatoid factor and anti‐citrullinated peptides in fibrotic interstitial lung disease 2022 ·Respirology ·Boyang Zheng, (unknown), Nathan Hambly, Kerri A. Johannson, Deborah Assayag, Jolene H. Fisher, H. Manganas, Veronica Marcoux, Nasreen Khalil, Martin Kolb, Christopher J. Ryerson, (unknown)	2
9	Impact of Concomitant Medication Burden on Tolerability of Disease-targeted Therapy and Survival in Interstitial Lung Disease 2022 ·Annals of the American Thoracic Society ·Yet H. Khor, Nicole Goh, Alyson W. Wong, Kerri A. Johannson, Veronica Marcoux, Jolene H. Fisher, Deborah Assayag, H. Manganas, Nasreen Khalil, Martin Kolb, Christopher J. Ryerson	9
10	Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease 2022 ·CHEST Journal ·Yet H. Khor, Mohammed A. Farooqi, Nathan Hambly, Kerri A. Johannson, Veronica Marcoux, Jolene H. Fisher, Deborah Assayag, H. Manganas, Nasreen Khalil, (unknown), Christopher J. Ryerson	7
11	Machine learning in radiology: the new frontier in interstitial lung diseases 2022 ·The Lancet Digital Health ·Hayley Barnes, Stephen M. Humphries, Peter M. George, Deborah Assayag, Ian Glaspole, John A. Mackintosh, Tamera J. Corte, Marilyn K. Glassberg, Kerri A. Johannson, Lucio Calandriello, (unknown), Athol U. Wells, Simon Walsh	55
12	Treatment Initiation in Patients with Interstitial Lung Disease in Canada 2021 ·Annals of the American Thoracic Society ·Deborah Assayag, (unknown), Kerri A. Johannson, Charlene D. Fell, Martin Kolb, Gerard Cox, Nathan Hambly, H. Manganas, Julie Morisset, Jolene H. Fisher, Shane Shapera, Andrea S. Gershon, Teresa To, Mohsen Sadatsafavi, Pearce Wilcox, Andrew J. Halayko, Nasreen Khalil, Christopher J. Ryerson	7
13	Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort study 2021 ·Respiratory Medicine ·(unknown), Shane Shapera, Christopher J. Ryerson, Deborah Assayag, Kerri A. Johannson, Charlene D. Fell, Julie Morisset, H. Manganas, Martin Kolb, Nathan Hambly, Gerard Cox, Nasreen Khalil, Veronica Marcoux, Pearce Wilcox, Teresa To, Mohsen Sadatsafavi, Andrew J. Halayko, Andrea S. Gershon, (unknown), Jolene H. Fisher	6
14	Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study 2021 ·European Respiratory Journal ·Tomoko Nakanishi, Agustin Cerani, Vincenzo Forgetta, Sirui Zhou, Richard J. Allen, Olivia C. Leavy, Masaru Koido, Deborah Assayag, Gísli Jenkins, Louise V. Wain, Ivana V. Yang, G.M. Lathrop, Paul J. Wolters, David A. Schwartz, J. Brent Richards	12
15	Long-term monitoring of patients with fibrotic interstitial lung disease: A Canadian Thoracic Society Position Statement 2020 ·Canadian Journal of Respiratory Critical Care and Sleep Medicine ·Jolene H. Fisher, Kerri A. Johannson, Deborah Assayag, Julie Morisset, (unknown), H. Manganas, Shane Shapera, Charlene D. Fell, Christopher J. Ryerson, Martin Kolb	10
16	Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease 2020 ·Thorax ·(unknown), (unknown), Alyson W. Wong, (unknown), Deborah Assayag, Kerri A. Johannson, Julie Morisset, Charlene D. Fell, Jolene H. Fisher, H. Manganas, Shane Shapera, Gerard Cox, Andrea S. Gershon, Nathan Hambly, Nasreen Khalil, Teresa To, Pearce Wilcox, Andrew J. Halayko, Martin Kolb, Christopher J. Ryerson	38
17	Patient gender bias on the diagnosis of idiopathic pulmonary fibrosis 2020 ·Thorax ·Deborah Assayag, Julie Morisset, Kerri A. Johannson, Athol U. Wells, Simon Walsh	28
18	Long-Term Azithromycin Therapy to Reduce Acute Exacerbations in Patients With Severe Chronic Obstructive Pulmonary Disease 2018 ·SSRN Electronic Journal ·(unknown), Deborah Assayag, (unknown), (unknown), (unknown), (unknown), (unknown), Pei Zhi Li, Jean Bourbeau	2
19	The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis 2015 ·Respiratory Medicine ·Deborah Assayag, Eric Vittinghoff, Christopher J. Ryerson, Elisabetta Cocconcelli, Roberto Tonelli, Xiaowen Hu, Brett M. Elicker, Jeffrey A. Golden, Kirk D. Jones, Talmadge E. King, Laura L. Koth, Joyce Lee, Brett Ley, Anthony K. Shum, Paul J. Wolters, Jay H. Ryu, Harold R. Collard	9
20	Rheumatoid Arthritis–associated Interstitial Lung Disease: Radiologic Identification of Usual Interstitial Pneumonia Pattern 2013 ·Radiology ·Deborah Assayag, Brett M. Elicker, Thomas H. Urbania, Thomas V. Colby, (unknown), Jay H. Ryu, Talmadge E. King, Harold R. Collard, Dong Soon Kim, Joyce Lee	98

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact